MedservRegis p.l.c., a provider of integrated logistics and engineering services to the energy and offshore industries, has announced a new unsecured bond issue available to existing bondholders through a rollover offer.
MeDirect Bank (Malta) plc is now accepting applications for the the Euro equivalent of €25,000,000 in MedservRegis p.l.c. unsecured Bonds due 2031 – 2036 issued in Euro (“EUR Bonds”) and US Dollar (“USD Bonds”).
Company Overview
MedservRegis p.l.c. operates across Europe, the Middle East, Africa, and the Americas, delivering integrated logistics, engineering, and supply chain solutions to the global energy sector. The Group supports both traditional oil and gas operations and the growing renewable energy market through services such as logistics base management, OCTG (Oil Country Tubular Goods) handling, engineering support, and end-to-end supply chain management. MedservRegis continues to focus on operational excellence, sustainability, and long-term growth.
For more information, visit www.medservregis.com.
Key Details of the Offer
- Rollover Option:
- Holders of the €4.5% 2026 Unsecured Bonds may roll over their existing holdings into the new €5.5% Unsecured Bonds 2031–2036.
- Holders of the US$5.75% 2026 Unsecured Bonds may roll over into the new US$6.5% Unsecured Bonds 2031–2036.
- Minimum Retention Requirement:
Existing bondholders must retain a minimum balance of €50,000 (for EUR bonds) or US$55,000 (for USD bonds) in their current holding. Partial rollovers are permitted only if the remaining balance meets these thresholds.
- Bond Denomination and Applications:
The new bonds are issued in denominations of €5,000 or US$5,000, and applications must be made in multiples of these amounts. Where an existing holding is not a multiple of 5,000, bondholders rolling over their entire holding will need to make a Cash Top-Up to reach the next multiple of 5,000. Cash Top-Ups apply only to full rollovers.’
- Excess Bonds:
Bondholders who roll over their entire holding may also apply for additional amounts, referred to as Excess Bonds, subject to availability and allocation.
- Non-Rollover Option:
Existing bondholders who choose not to exchange their current bonds will receive full repayment of capital and accrued interest (up to but excluding 5 February 2026) on the redemption date of 5 February 2026.
Application Process
Eligible investors can apply during the priority phase through MeDirect, subject to minimum subscription limits. Should the initial allocation remain undersubscribed, MeDirect will facilitate access to the Intermediaries’ Offer for other qualified investors wishing to participate in the new issue.
Full details about this bond are set out in the Base Prospectus and Final Terms dated 20 October 2025 on the issuer’s website accessible from https://medservregis.com/notifications-publications/.
Eligible MeDirect clients will receive a secure message outlining the application process. Retail investors must complete an appropriateness assessment by a licensed financial advisor prior to subscription. If you are interested in applying, please send a Secure Mail via the MeDirect platform or contact your Relationship Manager.
For further information, please call us on (+356) 2557 4400 or send an email to customerservice@medirect.com.mt.
The information set forth in this article is only for informative purposes and should not be construed as an offer to sell or solicitation of an offer to subscribe for or purchase any investment. The information provided is subject to change without notice and does not constitute investment advice or any guarantee of returns. Please consider the terms and conditions governing the relevant investment prior to making any investment decision. Investors should note that at worst they may lose all of their invested principal in the event of default, insolvency and/or bankruptcy of the relevant issue.
The financial instruments discussed are intended for retail clients, however, may not be suitable for all investors and investors must make their own informed decisions and seek their own advice regarding the appropriateness of investing in financial instruments or implementing strategies discussed herein.
MeDirect Bank (Malta) plc has based this document on information obtained from sources it believes to be reliable but which have not been independently verified. MeDirect Bank (Malta) plc does not therefore provide any guarantees, representations or warranties. The value of any investment or income may go up as well as down and past performance is no guarantee of any future performance. When an investment is denominated in a currency other than your local or reporting currency, changes in exchange rates may have an adverse effect on your investment.
MeDirect Bank (Malta) plc, company registration number C34125, is licensed by the Malta Financial Services Authority under the Banking Act (Cap. 371) and the Investment Services Act (Cap. 370). This material shall not be reproduced in any way, whether in whole or in part. Any unauthorised disclosure, use or dissemination, either in whole or in part, of the material contained within is strictly prohibited.
